Physician profile
Donald E Brown
NPI 1548377179
$424.54
in general payments reported to CMS, 2019-2025
10 companies · $72.39 in 2025
The $72.39 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $192 · 2020: $57.46 · 2021: $14.72 · 2022: $38.97 · 2023: $14.20 · 2024: $34.75 · 2025: $72.39.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $121.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $121.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $199.82 | 2019-2020 | |
| Covidien Lp | $49.69 | 2019-2020 | |
| Medtronic, INC. | $42.85 | 2025 | Endurant Iis |
| Bard Peripheral Vascular, INC. | $30.15 | 2023-2025 | Venovo, Pristine |
| Haemonetics Corporation | $25.10 | 2022 | |
| Inari Medical, INC. | $20.15 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Tela Bio, INC. | $14.72 | 2021 | |
| Abbott Laboratories | $14.60 | 2024 | Jeti All In One Non-Sterile Kit |
| Angiodynamics, INC. | $13.87 | 2022 | |
| Becton, Dickinson and Company | $13.59 | 2025 | Rotarexs 6 F X 135 Cm |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donald Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.